Brussels, May 2015
The European Federation for Exploratory Medicines Development (EUFEMED), a newly formed Federation of Early Phase associations; Club Phase 1 (France), BAPU (Belgium), AGAH (Germany) and AHPPI (UK), proudly hosted the 3rd Joint Conference of European Human Pharmacological Societies, which took place 21st and 22nd May 2015 in Brussels.
Delivered by an excellent panel of key industry representatives, the meeting provided an overview on Europe’s current global market position, advances in European clinical trial regulation and current issues in exploratory clinical drug development, attracting a wide audience of scientific, regulatory and academic professionals across Europe.